Cohen & Steers: Diversification From Mag 7
Finance

Cohen & Steers: Diversification From Mag 7

authorBy David Rubenstein
DateJul 13, 2026
Read time4 min

Cohen & Steers, Inc. (CNS) presents a compelling investment case, meriting a 'BUY' rating due to a confluence of favorable factors. The company is experiencing robust fund inflows, indicative of strong investor confidence, which has propelled its assets under management (AUM) to an impressive $93 billion as of Q1 2026. A significant portion of its AUM, approximately 48%, is allocated to Real Estate Investment Trusts (REITs), a sector currently benefiting from a strategic rotation and improving fundamental conditions in the property market. Furthermore, CNS boasts a low leverage profile, strong cash generation capabilities, and offers an attractive dividend yield of 3.5%, positioning it favorably for sustained shareholder returns. The firm's consistent outperformance against benchmarks, with 86% of AUM surpassing benchmarks over one year and 98% over three years, underscores its effective investment strategies.

The company's non-technology-focused investment approaches, particularly within U.S. REITs, distinguish it in a market often dominated by tech giants. This diversified approach, coupled with a forward price-to-earnings (P/E) ratio that is 37% below historical peaks, suggests that CNS stock may be undervalued, offering an appealing entry point for investors. As the landscape of exchange-traded funds (ETFs) continues to expand, Cohen & Steers is strategically poised to leverage this growth through continuous product innovation, further solidifying its market position and potential for future expansion.

Robust Growth and Market Outperformance Define Cohen & Steers

Cohen & Steers, Inc. (CNS) has garnered a 'BUY' recommendation, driven by substantial capital inflows into its funds and a notable resurgence in the performance of Real Estate Investment Trusts (REITs). The firm's assets under management (AUM) reached an impressive $93 billion by the first quarter of 2026, reflecting a period of significant expansion. A key highlight of CNS's strategy is its non-technology-centric investment approach, particularly its focus on U.S. REITs. This diversification stands out in a market often concentrated on technology stocks. The company's disciplined investment process has consistently led to superior returns, with 86% of its AUM outperforming their respective benchmarks over a one-year period and an even more remarkable 98% achieving outperformance over three years. This track record of consistent success underscores the efficacy of Cohen & Steers' investment methodologies and its ability to deliver value to its clients.

The strategic positioning of Cohen & Steers in the REIT sector is proving particularly advantageous. REITs, which constitute approximately 48% of the firm's total AUM, are currently experiencing a favorable market environment characterized by sector rotation and strengthening property market fundamentals. These conditions have translated into double-digit year-to-date returns for REITs, directly benefiting CNS's overall performance. Beyond its strong investment results, the company's financial health is robust, marked by a conservative leverage profile and strong cash generation. These attributes, combined with a compelling 3.5% dividend yield, position Cohen & Steers as an attractive option for income-focused investors. The company's forward price-to-earnings (P/E) ratio currently trades at a significant 37% discount compared to its historical highs, suggesting a potential undervaluation and an opportune moment for investment. Cohen & Steers is also actively pursuing product expansion and is well-prepared to capitalize on the ongoing growth in secular exchange-traded fund (ETF) trends, further cementing its competitive edge and future growth prospects.

Strategic Advantages and Future Prospects for Sustained Shareholder Value

Cohen & Steers (CNS) is distinguished by its strategic focus on non-technology investment avenues, prominently featuring U.S. REITs, which has been instrumental in attracting substantial fund inflows and fostering significant growth in its assets under management. The firm's AUM surged to $93 billion by the first quarter of 2026, a testament to its successful investment strategies. A critical component of its portfolio, REITs, have recently delivered double-digit year-to-date returns, benefiting from a broad market shift towards sector rotation and tangible improvements in property fundamentals. This strong performance underpins the 'BUY' rating for CNS, further supported by the company's attractive 3.5% dividend yield and a forward P/E ratio trading at a substantial discount compared to historical averages, indicating a potentially undervalued stock.

The firm's ability to consistently surpass benchmark returns—with 86% of its AUM outperforming over one year and 98% over three years—highlights the strength and effectiveness of its specialized investment management. This proven track record, coupled with a sound financial structure characterized by minimal leverage and robust cash flow generation, provides a solid foundation for consistent shareholder returns. Looking ahead, Cohen & Steers is well-positioned to leverage the increasing popularity of exchange-traded funds (ETFs) through ongoing product innovation and expansion. This forward-looking strategy, combined with its current operational strengths and favorable market conditions for REITs, is expected to drive continued growth and enhance long-term value for investors. The company's prudent financial management and strategic market positioning make it a resilient and promising investment in the evolving financial landscape.

More Articles
Finance
Top Personal Loan Options for Pool Installation
Considering a new swimming pool for your home? This comprehensive guide explores the best personal loan options available to finance this significant investment. We delve into various lenders, highlighting their rates, terms, and specific advantages, from rapid funding to accommodating lower credit scores. Discover how to secure the ideal loan for your dream pool project.
By David RubensteinJul 13, 2026
Finance
Baird International and Global Growth Funds: Q2 2026 Performance Review
This report analyzes the performance of Baird's International and Global Growth Funds in Q2 2026. The International Growth Fund returned +10.39%, underperforming the MSCI ACWI ex-U.S. Index® ND's +14.49%. Key detractors included Alibaba and Lululemon, while Recruit and ASML contributed positively. The Global Growth Fund returned +12.18%, lagging behind the MSCI ACWI Index® ND's +14.93%, with Regeneron and TJX as major detractors, and Micron and ASML as top contributors.
By Mariana MazzucatoJul 13, 2026
Finance
HCA Healthcare: A Dominant Force in the U.S. Hospital Market
HCA Healthcare, the largest for-profit hospital operator in the U.S., stands out for its strong local market presence, efficient operations, strategic capital allocation, and consistent demand for its services. The company's focus on expanding outpatient care and its resilient financial performance, even during economic downturns, underscore its robust business model and long-term growth potential. With a commitment to internal development and shareholder returns, HCA Healthcare offers an attractive investment opportunity.
By Mariana MazzucatoJul 13, 2026
Finance
Analyzing RiverNorth Opportunities Fund: Common vs. Preferred Stock
This analysis delves into the RiverNorth Opportunities Fund (RIV) and its preferred stock (RIV.PR.A). While RIV boasts a high dividend yield, its common stock presents greater risk. We explore RIV's diversified portfolio, current trading discount, historical performance relative to peers, leverage, and expense ratio. The preferred stock, RIV.PR.A, offers an attractive current yield, strong credit rating, and capital protection, making it a potentially smarter choice for investors seeking stability and income.
By Robert KiyosakiJul 13, 2026
Finance
Cal-Maine Foods: A Resilient Investment Amidst Shifting Egg Market Dynamics
Cal-Maine Foods (CALM) maintains a 'buy' rating, demonstrating resilience through its focus on specialty eggs and a significant surge in prepared foods sales. This strategic pivot helps mitigate the impact of fluctuating egg prices, reinforcing the company's strong financial position with substantial net cash. The resolution of the DOJ probe further strengthens its investment appeal, promising positive returns for long-term investors.
By Michele FerreroJul 13, 2026